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Chapter 1 
 
 
 
 
 
 
 
 
 
Added value of 
99m
Tc-HMPAO-labeled leukocytes 
SPECT/CT imaging in the characterization and 
management of patients with infectious endocarditis 
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ABSTRACT 
Clinical performance of the Duke Endocarditis Service criteria to establish the diagnosis of 
infectious endocarditis (IE) can be improved through functional imaging procedures such as  
radiolabeled leukocytes (
99m
Tc-HMPAO-WBC). Methods: We assessed the value of 
99m
Tc-
HMPAO-WBC scintigraphy including SPECT/CT acquisitions in a series of 131 consecutive 
patients with suspected IE. Patients with permanent cardiac devices were excluded. 
99m
Tc-
HMPAO-WBC scintigraphy results were correlated with transthoracic (TTE) or 
transesophageal (TEE) echocardiography, blood culture and the Duke criteria. Results: 
Scintigraphy was true positive in 46/51 and false negative in 5/51 cases (90% sensitivity, 94% 
NPV, 100% specificity and PPV). No false positive results were found. In 24/51 patients with 
IE we also found extracardiac uptake, indicating septic embolism in 21/24. Despite septic 
embolism was found in 11/18 cases of Duke “definite IE”, most of the added value from the 
99m
Tc-HMPAO-WBC scan for decision-making was seen in patients in whom the Duke 
criteria yielded "possible" IE. The scan was particularly valuable in patients with negative 
and/or difficult-to-interpret echocardiographic findings since it correctly classified 11/88 of 
these patients as having IE. Furthermore, 3 patients were falsely positive at echocardiography 
but correctly negative at 
99m
Tc-HMPAO-WBC scintigraphy. Conclusions: Our results 
demonstrate 
99m
Tc-HMPAO-WBC scintigraphy ability to reduce the rate of misdiagnosed IE 
when combined to the standard diagnostic tests (a) in patients with high clinical suspicion but 
inconclusive echocardiographic findings; (b) for the differential diagnosis between septic and 
sterile vegetations detected at echocardiography; (c) when echocardiographic, laboratory and 
clinical data are contradictory, as also to exclude valve involvement (especially of a prosthetic 
valve) during febrile episodes, sepsis or post-surgical infections.  
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INTRODUCTION 
The incidence of infectious endocarditis (IE), is approximately 2-4 cases per 100,000 
persons/year (1). At present, 25-50% of the cases occur in patients older than 60 years (2). 
 The diagnosis of IE, first suspected on clinical ground, is further supported either by 
detecting a vegetation at transthoracic (TTE) or transesophageal (TEE) echocardiography, 
and/or by positive blood culture (3). In most institutions the final diagnosis is established 
using the Duke Endocarditis Service criteria (4), which also entail echocardiographic findings. 
Overall sensitivity is about 80% (5). However, in some instances blood culture or 
echocardiography are inconclusive, thus leading to a high proportion of unconfirmed cases of 
suspected IE. Indeed, up to 24% of the patients with pathologically proven endocarditis were 
misclassified as "possible" IE based on Duke criteria alone (5). 
 Attempts have been made at improving the diagnostic performance of the above 
criteria, and modifications that consider several additional clinical and microbiological 
parameters have been proposed (6). The so-called modified Duke criteria are now 
recommended for diagnostic classification (7). Traditional diagnostic criteria may also be 
integrated with information derived from radionuclide imaging, given the ability to localize 
functional hallmark of infection as represented by increased radiolabeled leukocytes 
recruitment. Using three-dimensional reconstruction of hybrid SPECT/CT or PET/CT images 
it’s possible to detect and precisely localized throughout the body all the sites of infections 
represented by areas of radiopharmaceutical uptake. In association with echocardiography, 
this imaging technique can be employed to confirm or rule out IE in equivocal and/or 
difficult-to-explore situations (i.e., marantic vegetations, artefacts caused by mechanical 
prosthesis). Furthermore, scintigraphy can also reveal the presence of extra-cardiac infection 
sites as the consequence of septic embolism originated from IE (8).  
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In this study we assessed the added value(s) of SPECT/CT with 
99m
Tc-HMPAO-
labeled autologous leukocyte (
99m
T-HMPAO-WBC) in the characterization of patients with 
suspected or established IE, as defined according to Duke criteria. 
 
MATERIALS AND METHODS 
Patient Population  
Between October 2005 and December 2010, a total of 185 consecutive patients were referred 
for scintigraphy with 
99m
T-HMPAO-WBC for suspected IE. Fifty-four of these patients were 
excluded from the present analysis because they were bearing permanent cardiac devices, a 
condition that might introduce confounding factors linked to the different mechanism of 
infection (9). Therefore, the population for the present work included the remaining 131 
patients (45 women and 86 men, mean age 62.8±16.6 years), in whom IE was suspected, or 
established as definite according to the Duke criteria; in the latter case, scintigraphy was 
performed to exclude septic embolism. All patients had undergone clinical examination, blood 
tests including WBC counts, CRP, ESR, acute phase proteins, electrophoresis, urinalysis and 
echocardiography (either TTE, TEE or both). Three sets of blood cultures including at least 
one aerobic and one anaerobic from a peripheral vein were performed for all patients (10). 
The main clinical features and risk factors of the patients are summarized in Table 1.  
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Table 1. Main features of the 131 patients included in the study. 
Age (years) Mean ± SD Median Range 
 62.8 ± 16.6 66 19-89 
 
Sex 
 
Women 
 
Men 
 
 45/131 (34%) 86/131 (66%)  
 
Risk factors 
 
Diabetes 
 
Renal failure 
 
Cutaneous lesions 
 20/131 (15%) 24/131 (18%) 10/131 (8%) 
 
Blood tests 
 
ESR 
 
CR 
 
Leukocytosis 
 110/131 (84%) 78/131 (60%) 55/131 (42%) 
 
Blood culture 
 
Positive 
 
Negative 
 
 67/131 (51%) 64/131 (49%)  
 
Duke criteria 
 
Definite 
 
Possible 
 
Rejected 
 28/131 55/131 48/131 
 
Final diagnosis of IE, or exclusion of this condition and identification of an alternative cause 
of disease was defined based on the final microbiological (n=20) or clinical diagnosis (n=31), 
with clinical follow-up of 12 months for all patients. Based on these combined parameters, IE 
was confirmed in 51 out of the 131 patients, that is, in 24/28, 25/55 and 2/48 of the cases in 
which IE had been classified as definite, possible, or rejected, respectively, according to Duke 
criteria. 
 In the 51 patients who were eventually diagnosed as having IE, infection involved 
more frequently the aortic valve and affected almost equally native valves either biological or 
mechanical prosthetic implants (Table 2). In patients with prosthetic valves early IE (< 2 
months from valve replacement) was present in 9/35 patients, semi-late IE (between 2 and 12 
months) in 11/35 and late-onset IE in 15/35 (Table 2).  
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Table 2. Site of IE, type of valve and time of infection onset. 
Type of valve  Native Biological prosthesis Mechanical 
prosthesis 
 
 16/51 (31%) 19/51 (38%) 16/51 (31%)  
 
Site of IE 
 
Aortic 
 
Mitral 
 
Tricuspid 
 
Aortic + 
mitral 
Native 9/30 (30%) 6/19 (32%) 1/1 (100%) - 
Biological 
prosthesis 
10/30 (33%) 8/19 (42%) - 1/1 (100%) 
Mechanical 
prosthesis 
11/30 (37%) 5/19 (26%)* - - 
 
Type of infection 
 
Early IE 
 
Semi-late IE 
 
Late IE 
 
 9/35 (26%) 11 (31%) 15 (43%)  
 
Time from valve 
replacement 
(months) 
 
mean 1.39 
range 0.5-2 
 
mean 6 
range 3-10 
 
mean 51.4 
range 6-204 
 
    (*) including 2 patients with anuloplasty. 
 
Staphylococcus spp. was the microorganism more frequently responsible for the 
infection (24/51), followed by Enterococcus spp. (11/51), Streptococcus spp. (10/51), and P. 
aeruginosa (4/51). Haemophilus and Candida were found in 2/51 patients each. 
Radiolabelling of Autologous Leukocytes and Image Acquisition Protocol 
Autologous radiolabeled WBCs were prepared according to the EANM Guidelines for the 
labeling of leukocytes with 
99m
Tc-HMPAO (11,12). Radiolabelling efficiency was always 
between 70-85%, and viability of the radiolabeled leukocytes was always tested by the Tripan 
blue exclusion test before reinfusion. 
 Whole body and spot planar images were obtained after 30 minutes (early), then 4-6 
and 20-24 hours (delayed images) after reinfusion of 370-555 MBq of 
99m
Tc-HMPAO-WBC. 
SPECT/CT of the chest was performed in all patients at 6 hours and repeated at 24 hours in 
case of negative or doubtful imaging at 6 hours. Images were acquired using a dual-head, 
variable-angle SPECT/CT gamma camera (Hawkeye, GE Healthcare). The low-dose CT 
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transmission scan was acquired for 16 seconds over 220° for each transaxial slice. The full 
FOV consisting of 40 slices was completed in 10 minutes. The transmission data were 
reconstructed using filtered back-projection to produce cross-sectional images. Resolution of 
the CT scan was 2.2 mm and localization images were produced with a 4.5-mm pixel size, 
similar to the nuclear medicine emission images. The CT scans were reconstructed into a 
256 256 matrix. The SPECT component of the same FOV was acquired using a 128 128 
matrix, 360° rotation, 6° angle step, and 40/60-sec-per-frame acquisition time at 6 and at 24 
hours, respectively. Both CT-attenuation corrected and non-corrected SPECT images were 
evaluated in the coronal, transaxial, and sagittal planes, as well as in tridimensional maximum 
intensity projection (MIP) cine mode. Matching pairs of x-ray transmission and radionuclide 
emission images were fused using the Xeleris software, and hybrid images of overlying 
transmission and emission data were generated. 
Interpretation Criteria 
Two experienced nuclear physicians aware of the patients’ clinical history and of the 
results of prior conventional imaging tests reviewed independently the planar scans and the 
SPECT/CT images, with regard to the presence and location of any focus of abnormal 
radioactivity accumulation indicating infection. Preliminary analysis of the SPECT/CT 
images included visual inspection to exclude misregistration between the SPECT and the CT 
components. 
 The scintigraphic studies were classified as negative when no sites of abnormal uptake 
were observed at SPECT/CT images, or positive for infection when at least one focus of 
abnormal uptake characterized by time-dependent increase in radioactivity from early planar 
to delayed images was observed (13). This time-dependent pattern of uptake is especially 
relevant for the cardiac region, considering that physiologic accumulation of radiolabeled 
leukocytes in the bone marrow (as in the sternum, overlying the heart) early after reinfusion 
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can interfere with interpretation of the planar images. When present, focal uptake indicating 
infection was further classified as pertaining to the heart and/or to extracardiac sites. 
 The contribution of SPECT/CT was considered with special attention to the possibility 
of anatomically localizing the exact site of infection, particularly for the heart region. In fact, 
neither the planar nor the stand-alone SPECT images allow to localize areas of focal uptake of 
the radiolabeled leukocytes in the cardiac region as pertaining or not to endocardium.   
Data Analysis 
Results of 
99m
Tc-HMPAO-WBC scintigraphy were correlated with those of TTE, TEE, 
blood culture and the Duke criteria. The ability to detect or to exclude the presence of IE was 
defined based on the final microbiological or clinical diagnosis. Furthermore, in patients with 
known IE the ability to identify septic emboli and metastatic sites of infection was considered, 
in order to assess the ability of 
99m
Tc-HMPAO-WBC scintigraphy to define disease burden. 
 No comparative analysis was performed between the stand-alone SPECT and the 
SPECT/CT findings concerning intracardiac location of infection, because in case of focal 
uptake in the cardiac region no further topographic localization is possible with the former 
sets of images, considering that the mitral valve and, i.e., the aortic valve (the most frequent 
site of IE) are <1 cm apart one from each other. 
Statistical Analysis 
All values are expressed as median and range, as customary for nonparametric data. 
 
RESULTS 
By adopting the interpretation criteria described above for scintigraphic detection of infection, 
it was possible to classify all the scans as either frankly positive or frankly negative, therefore 
without any equivocal result at scintigraphy. With these criteria, 
99m
Tc-HMPAO-WBC 
scintigraphy was totally negative in 34/131 patients for either cardiac and/or extracardiac sites 
of focal uptake indicating infection, without any discordant results between planar and 
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SPECT/CT acquisitions. At least one abnormal area with focal uptake of the radiolabeled 
leukocytes was detected in 97 out of the 131 patients included in this study. When considering 
the 51 patients with final diagnosis of IE, the uptake was either limited to the heart only 
(n=23; Figures 1, 2 and 3), both at the heart and at extracardiac sites (n=23), or at extracardiac 
sites only (1 case with septic embolism in the spleen, which was therefore considered as a 
false negative scan for IE).  
 
Figure 1. 
99m
Tc-HMPAO-WBC scintigraphic images in a patient with aortic endocarditis. 
The MIP image (A) demonstrates focal increase of radiolabeled WBCs in the heart region. 
Transiaxial SPECT/CT images (panel B) show that such focal uptake is localized at the 
mechanical prosthesis of the aortic valve (CT section in left panel, fused SPECT/CT section 
in center panel, SPECT right panel).  
 
 
Figure 2. 
99m
Tc-HMPAO-WBC SPECT/CT images obtained in a patient with positive blood 
culture and fever arose few months after substitution of the mitral valve with a mechanical 
prosthesis (coronal sections in upper panel, transaxial sections in lower panel; CT images in 
left panels, SPECT/CT images in central panels, SPECT images in right panels). SPECT 
images demonstrate a clear focus of uptake in the right heart, identified as endocarditis of the 
native tricuspid valve by the superimposed SPECT/CT images (central panels). Endocarditis 
of  the mechanical prosthesis, the expected site of infection before performing 
99m
Tc-
HMPAO-WBC, was therefore excluded. 
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Figure 3. 
99m
Tc-HMPAO-WBC scintigraphy demonstrating the value of SPECT/CT for 
precisely localizing the site of infection. (A) Planar anterior and posterior views (anterior in 
left panel, posterior in right panel), where focal uptake of radiolabeled WBCs mimic sternal 
osteomyelitis. (B) Coronal, sagittal, and transaxial CT sections in left panels, fused 
SPECT/CT sections in middle panels and SPECT sections in right panels. The tomographic 
images correctly localize uptake of 
99m
Tc-HMPAO-WBCs at the mitral valve prosthesis. 
 
 
 
99m
Tc-HMPAO-WBC SPECT/CT was therefore true positive in 46/51 and false 
negative in 5/51 cases. The 5 false negative findings for IE at 
99m
Tc-HMPAO-WBC 
scintigraphy occurred in patients with small valve vegetations (<6 mm) and in the presence of 
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infection from Enterococcus (n=4) or Candida (n=1); all such patients were under high-dose 
antimicrobial therapy at the time of scintigraphy. There were no false positive scans for 
infection of the cardiac valves. 
 Although both planar and stand-alone SPECT images were sufficiently accurate to 
detect the presence of infection involving the heart in the majority of the patients (there were 
in fact only 4 false negative planar scans due to accumulation of the radiolabeled leukocytes 
hidden by the sternum or the ribs), only after co-registration with CT it was possible to 
precisely discriminate the localization of 
99m
Tc-HMPAO-WBC uptake (i.e. especially mitral 
versus aortic valves, given their proximity, metal devices, or surgical stitches/clips) from any 
non-cardiac site of infection in the mediastinal space. Out of the total 89 sites of increased 
99m
Tc-HMPAO-WBC uptake in the chest, fused SPECT/CT imaging demonstrated heart 
valve localization in 44 cases, as opposed to non-cardiac-valve localizations due to infection 
of aortic graft (n=11), sternum osteomyelitis (n=13), mediastinitis (n=3), and lung infection 
(n=17). For areas with focal 
99m
Tc-HMPAO-WBC uptake located outside the thorax, major 
impact of the SPECT/CT findings was observed for infection sites in the CNS and head-and-
neck lesions, as well as to discriminate between bone infection and soft tissue infection. In 
particular, the exact sites of 
99m
Tc-HMPAO-WBC accumulation were diagnosed as CNS, 
nasal and maxillary sinus infections (in 3 and 5 cases, respectively), spleen embolism (n=4) or 
bone, soft tissue or prosthetic joint infections (22 cases overall, involving spine in 10 cases).  
 Septic embolism was detected in 41% of patients (Figure 4).  
 
Figure 4. Examples of septic embolism at different sites as detected by 
99m
Tc-HMPAO-WBC 
SPECT/CT. (A) Patient with septic embolism in the left lung (coronal, sagittal and transaxial 
CT sections in left panels, fused SPECT/CT sections in middle panels, and SPECT sections in 
right panels). (B). Patient with spetic embolism in the spleen, where infection shows as a 
photopenic area in the splenic parenchyma (transaxial CT section in left panel, fused 
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SPECT/CT section in center panel, SPECT in right panel). (C) Patient with septic embolism 
in the spine (coronal, sagittal and transaxial CT sections in left panels, fused SPECT/CT 
sections in middle panels, and SPECT sections in right panels). Similarly as in the case of the 
spleen, infection shows as a photopenic area which in this patient involves two vertebral 
bodies.  
 
 
Three cases interpreted as septic embolism at 
99m
Tc-HMPAO-WBC scintigraphy were instead 
false-positive, due to active vasculitis of the aortic arch, an isolated vertebral metastasis from 
prostate cancer, and an osteoporotic vertebral crush, respectively. There were 8 false negative 
scans for extracardiac infection, due to kidney (n=3) or cerebral septic embolism (n=5) (all 
detected by the CT or MRI imaging). 
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 Table 3 correlates the SPECT/CT results and the Duke classification in the 51 patients 
with final diagnosis of IE. Most of the added value from the 
99m
Tc-HMPAO-WBC scan for 
decision-making was seen in patients in whom the Duke criteria yielded "possible" IE. 
 
Table 3. Results of 
99m
Tc-HMPAO-WBC scintigraphy in patients with final diagnosis of IE, 
stratified according to Duke criteria. 
  
  Positive scan Negative scan 
  cardiac only 
cardiac and 
extracardiac 
extracardiac 
only  
 
Duke 
criteria 
Definite IE 
(24/51) 9 11* 0 4 
Possible IE 
(25/51) 13 11
#
 1* 0 
Rejected IE 
(2/51) 1 1* 0 0 
     (*) with septic embolism consequent to IE; (
#
) 8 patients with septic embolism, 1 with vasculitis,  
      and two false-positive scans due to vertebral crush and metastasis from prostate cancer.  
 
Table 4 shows the correlation between echocardiographic and 
99m
Tc-HMPAO-WBC 
scintigraphic findings. The scan was particularly valuable in patients with negative and/or 
difficult-to-interpret echocardiographic findings due to several circumstances, such as 
mechanical valve implants or the presence of huge calcifications (in a diabetic patient 
undergoing dialysis). Furthermore, 3 patients were falsely positive at echocardiography but 
correctly negative at 
99m
Tc-HMPAO-WBC scintigraphy: these patients had marantic 
vegetations. 
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Table 4. Results of 
99m
Tc-HMPAO-WBC scintigraphy in patients with final diagnosis of IE, 
stratified according to echocardiography (ECHO). 
  Positive scan Negative scan 
 
ECH
O 
positive (40/51) 35 5 
 negative (11/51) 11 0 
  
Table 5 correlates the results of 
99m
Tc-HMPAO-WBC scintigraphy and blood culture. 
The most striking result was a positive scan observed in patients with negative blood culture; 
such high negative fraction of false-negative result of the blood culture could be linked to 
high-dose antibiotic therapy. 
 
Table 5. Results of 
99m
Tc-HMPAO-WBC scintigraphy in patients with final diagnosis of IE, 
stratified according to blood culture. 
                                                 Positive  scan Negative scan 
  cardiac only 
cardiac and 
extracardiac 
extracardiac 
only 
 
Blood 
culture 
positive (32/51) 15 14* 0 3 
 
negative 
(19
#
/51) 
8 9
§
 1 1 
(*) 11/14 with septic embolism consequent to IE and two false-positive scans due to vertebral crush; (
#
) during 
antibiotic therapy in 44/64 patients; (
§
) 8/9 with septic embolism consequent to IE and one false-positive scan 
due to vasculitis. 
 
 Table 6 shows results of all the diagnostic procedures in patients without IE. Out of 
the 50/80 patients without IE who exhibited a positive 
99m
Tc-HMPAO-WBC scintigraphy 
(only at extracardiac sites), the scan correctly classified such patients as having either 
osteomyelitis (n=22), peripheral vascular graft infection (n=12), lung infection (n=7), 
mediastinitis (n=5), or cholecystitis (n=2). In 2 cases focal uptake of the radiolabeled 
leukocytes in the spine was falsely positive for infection, as it was due to vertebral crush 
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caused by osteoporosis in one case, by metastasis from a melanoma with unknown primary 
site in the other case. 
 
Table 6. Results of all the diagnostic procedures in the 80 patients without IE (ECHO = 
echocardiography).  
 
99m
Tc-HMPAO-WBC scintigraphy 
Positive scan*  Negative scan 
ECHO  positive (n = 3/80) 0 3 
 
negative (n = 
77/80) 0 77 
Blood culture 
positive (n = 
35/80) 26 9 
 
negative (n = 
45/80) 24 21 
Dukes 
criteria 
Definitive IE (n = 
4) 4 0 
Possible IE (n =30) 19 11 
Rejected IE (n 
=46) 27 19 
     *all patients presented only with extracardiac sites of radiopharmaceutical uptake. 
 
DISCUSSION 
The diagnosis of IE is becoming progressively more challenging due to a variety of factors. 
These include the indiscriminate use of antimicrobial agents in some clinical settings, the 
increased proportion of individuals with predisposing and/or underlying conditions (i.e., frail 
and elderly, immunosuppressed persons), as well the increasing number of interventional 
cardiovascular procedures and placement of valve prosthesis, intravascular, or cardiac 
devices. Mortality of IE remains high when this condition is undiagnosed, therefore not 
adequately treated (14). Early diagnosis and prompt institution of appropriate antibiotic 
therapy reduce septic embolism and mortality (15); therefore, the identification of patients at 
highest risk of death may offer the opportunity to change the course of the disease and 
improve prognosis.  
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 Because of the ability to detect endocardial vegetations (16), abscess (17) as well as 
intra-cardiac complications (i.e., valve perforation and chordal rupture) (18), 
echocardiography is the indirect method of choice for investigating patients with clinical 
suspicion of IE (19,20). Furthermore, some echocardiographic features such as vegetation size 
(higher risk for lesions >10 mm in diameter and for vegetations that are increasing in size), 
number (multiple) and features (mobile but pedunculated, noncalcified, prolapsing) (20) may 
be also used to predict the potential embolic burden of IE. However, the presence of 
prosthetic valves consistently decreases sensitivity and specificity of echocardiography, to 
about 20% for TTE and around 90% (in the hands of an experienced operator) for TEE (8). In 
approximately 15% of the cases, echocardiography can be false positive (because thickened 
valves, nodules, or valvular calcifications are misinterpreted as vegetations) (4), while a 
similar proportion can be false negative (4). Thus, echocardiographic findings alone cannot 
always definitely confirm nor exclude the clinical suspicion of IE. Since echocardiography 
represent the backbone of Duke criteria, this suboptimal diagnostic accuracy translates into a 
relatively high proportion of the cases classified as "possible" IE; yet, about 24% of such 
cases are eventually diagnosed to have indeed IE (5). 
 Additional potentially misleading factors in the Duke's classification include some 
well-known pitfalls in blood culture (antimicrobial treatment, subacute right-sided and mural 
endocarditis (21), fungi, slow-growing and difficult to identify organisms) (22), and 
ambiguous symptoms without any of the classical stigmata of valvular infection. 
 A functional imaging modality such as radionuclide imaging, capable of 
characterizing specific features of the endocardial vegetations, may contribute to solve 
clinical dilemmas in such conditions. In our experience, when the results of 
99m
Tc-HMPAO-
WBC scintigraphy were associated with either a positive echocardiography or a positive 
blood culture no cases of IE went undiagnosed. In particular, the radiolabeled leukocyte scan 
facilitated the diagnosis of IE in challenging situations for echocardiography, as in the 
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presence of mechanical prosthetic valve, anuloplasty rings, calcifications, and/or nonbacterial 
thrombotic vegetations. Furthermore, 
99m
Tc-HMPAO-WBC scintigraphy allowed to exclude 
valve infection in patients with concomitant risk factors, non-diagnostic echocardiographic 
findings, positive blood cultures (37% of the cases in our series), or to identify other focal 
infections different from IE (as occurred in 38% of the overall 131 patients). 
99m
Tc-HMPAO-
WBC scintigraphy can therefore be considered as the second-line test of choice in patients 
with prosthetic valve/device, fever, positive blood cultures and equivocal TTE/TEE findings. 
 This study confirms that 
99m
Tc-HMPAO-WBC scintigraphy is a crucial imaging 
modality also for localizing sites of infection in patients with symptoms and signs and 
laboratory findings of sepsis (increased ESR, CRP, and WBC count) (12) with either a 
positive or a negative blood culture. In these patients generally neither TEE nor TTE are used 
for screening purposes (4) and, therefore, the heart region should always be carefully 
evaluated when analysing the 
99m
Tc-HMPAO-WBC scan. 
 The possibility of acquiring whole-body images and additional planar and SPECT/CT 
spot images constitutes an invaluable aid for detecting septic embolism and metastatic sites of 
infection, as observed in our patients population. In particular, septic embolism was detected 
even in the absence of the typical echocardiographic predictors of systemic embolism (8,20).  
 These results refer only to patients with IE arising on native and prosthetic valves 
since we intentionally excluded patients with device related infection.  In fact, we consider 
not possible to apply the same diagnostic algorithm intended for IE to this different clinical 
entity. 
 Specific methodology-related issues must be properly addressed in order to ensure 
adequate scintigraphic acquisitions. Images should be acquired in time-mode, compensating 
for isotope decay at each time point. In case of equivocal findings at 6 hours SPECT/CT 
imaging of the thorax, images should be repeated also at 24 hours. Images should be analysed 
using the same scale frame to easily identify any focal area of activity that increases over time 
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or modifies its shape from early to late images. Both CT-attenuation corrected and non-
corrected images should be always inspected side by side, to minimise metal-related artefacts. 
Quantitative analysis of target/background (T/B) ratios was not necessary in these patients. 
SPECT/CT is mandatory to correctly interpret and localize sites and extension of radiolabeled 
leukocyte uptake indicating infection (23), to discriminate involvement of the heart valve or 
prosthesis from uptake around the prosthesis. Furthermore, in cases with positive scintigraphy 
in the cardiac region SPECT/CT imaging can discriminate endocardial infections from all 
other possible causes of post-surgical fever, i.e., mediastinitis, osteomyelytis of the sternum or 
ribs, wound infections. 
No false positive findings were found, particularly in patients with early IE evaluated 
within the first two months from the surgical procedure, suggesting that adequate acquisition 
protocol and interpretation criteria can optimize specificity of the scan also in this clinical 
setting. On the other hand, the false negative scans observed in presence of IE sustained by 
Candida spp. or Enterococcus spp. may be explained by the ability of these micro-organisms 
(as well as others such as S. epidermis) of forming a "biofilm" that results in resistance to 
antimicrobial treatment and escape from the host defence mechanisms (24). Additionally, 
altered neutrophil recruitment at the primary site of IE by E. faecalis extracellular proteases 
constitute a further mechanism of innate immune response impairment (25). Such 
mechanisms might reduce sensitivity of scintigraphy with radiolabeled leukocytes in patients 
with IE. However, in our experience the reduced sensitivity of 
99m
Tc-HMPAO-WBC 
scintigraphy was counterbalanced by the association with echocardiography. 
 Both false negative and false positive findings were also observed in our patients' 
group regarding distant septic embolism. In particular, the typical 
99m
Tc-HMPAO-WBC 
scintigraphic pattern of spleen embolism and spondilodiscitis represented by a cold spot (26) 
may be also present in other benign or malignant conditions. Thus, despite highly suggestive 
for septic embolism, such finding in patients with IE should be confirmed with additional 
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diagnostic imaging, as MRI. Finally, it is reasonable to assume that the availability of new 
generation SPECT/CT scanners with a more advanced CT component will further increase 
diagnostic accuracy, particularly when evaluating the CNS and bone. Alternatively, PET/CT 
imaging may be proposed to improve spatial resolution. In this regard, preliminary data have 
demonstrated significant uptake of [
18
F]FDG both in infected endocardial vegetations and at 
metastatic sites of infection (27-30). However, [
18
F]FDG uptake is observed in a variety of 
benign and malignant conditions such as inflammation or tumours (31), thus reducing its 
specificity. Moreover, special caution should be employed when interpreting of [
18
F]FDG 
uptake in the cardiac region, due to the high number of possible causes other than IE for a 
positive scan: recent thrombi (32), soft atherosclerotic plaques (33), vasculitis (34), primary 
and metastatic cardiac tumors (35,36), or simply post-surgical inflammatory reaction (37). In 
the clinical routine, focal areas of [
18
F]FDG uptake at heart site in the absence of IE are quite 
commonly observed (unpublished data, Figure 5).  
 
Figure 5. False positive [
18
F]FDG PET/CT result in a patient with fever. The area of 
increased [
18
F]FDG uptake suspected for endocarditis at a mitral valve mechanical prosthesis 
(A, central panel fused transaxial PET/CT and right panel PET stand alone) turned out to be 
negative in the 
99m
Tc-HMPAO-WBC SPECT/CT (B; central panel fused transaxial 
SPECT/CT and right panel SPECT) clinical follow-up confirmed the absence of infection. 
Left column, CT transaxial image. 
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The possibility of efficient radiolabelling of autologous leukocytes with positron emitting 
radionuclides can be expected to change the whole scenario of PET imaging for patients with 
suspected IE. In this regard, intense [
18
F]FDG-WBC uptake at the valve site has been 
described for the only patient with IE ever reported up to now (38). Unfortunately, the 
physical half-life of 
18
F is too short to encompass the whole kinetics of leukocyte migration 
into sites of infection, thus making a major limit for the use of this method in this clinical 
setting.  
 
CONCLUSION 
In conclusion, our experience supports the use of scintigraphy with 
99m
Tc-HMPAO-WBC in 
patients with high clinical suspicion of IE, in order to confirm the diagnosis in doubtful 
circumstances and/or to detect sites of septic embolism. The rate of misdiagnosed IE can be 
reduced with the use of 
99m
Tc-HMPAO-WBC (a) in patients with high clinical suspicion but 
inconclusive echocardiographic findings; (b) for the differential diagnosis between septic and 
sterile vegetations detected at echocardiography; (c) when echocardiographic, laboratory and 
clinical data are contradictory, as also to exclude valve involvement (especially of a prosthetic 
valve) during febrile episodes, sepsis or post-surgical infections.  
SPECT/CT is necessary to demonstrate and localize 
99m
Tc-HMPAO-WBCs at native or 
prosthetic valves, thus confirming the diagnosis of IE. Furthermore, whole-body images 
followed by additional planar and SPECT/CT spot images allow to detect distant sites of 
septic embolism, thus constituting an invaluable aid of this scintigraphic procedure. Negative 
results in presence of a typical echocardiographic pattern for IE should be carefully evaluated, 
since false negative findings due to limited spatial resolution or non-leukocyte recruiting 
microorganisms can be encountered.  
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Chapter 2 
 
 
 
 
 
 
 
 
 
 
Clinical impact of of 
99m
Tc-HMPAO-labeled leukocytes 
scintigraphy in the diagnostic workup of high risk patients 
with suspected device related infections 
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ABSTRACT 
Use of cardiovascular implantable electronic device has increased significantly over the last 
decade due to growing evidence of improved quality of life and survival among certain 
groups of patients. The infection rate of cardiac device varies widely between 1% and 7% and 
is associated with significant morbidity and mortality. The aim of this study is the 
investigation of the potential of 
99m
Tc-HMPAO autologous leukocyte SPECT/CT in patients 
with suspected device infection to determine the performances of this functional tests to guide 
clinical decisions. Methods: We assessed the value of 99mTc-HMPAO-WBC scintigraphy 
including SPECT/CT acquisitions in a series of 63 consecutive patients with known or 
suspected cardiac device infections. 99mTc-HMPAO-WBC scintigraphy results were correlated 
with transthoracic (TTE) or transesophageal (TEE) echocardiography and the Duke criteria. 
Results: Scintigraphy was true positive in 30/32 and false negative in 2/30. There were no 
false positive scans for CDIE infection. Sites of WBC uptake consistent with additional 
infections (n=38) are also reported, with particular attention to the presence of concomitant 
infectious endocarditis (n=6) cases and distant embolisms (n=15). Conclusions: Our results 
supports the use of scintigraphy with 99mTc-HMPAO-WBC in patients with high clinical 
suspicion of CIED infection. 99mTc-HMPAO-WBC scan results particularly useful in the 
evaluation of  the pocket and  the lead portion between pocket and superior cava 
debouchment, traits which remain unexplored by TEE. 
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INTRODUCTION 
Use of cardiovascular implantable electronic device (permanent pacemakers, 
implantable cardioverter/defibrillator or cardiac resynchronization therapy device with or 
with-out defibrillators, CIED) has increased significantly over the last decade due to growing 
evidence of improved quality of life and survival among certain groups of patients (1,2,3). 
Associated complications, particularly infections have increased disproportionally higher than 
newly implanted devices (4,5,6,7). The infection rate of cardiac device varies widely between 
1% and 7% (8,9) and is associated with significant morbidity and mortality (10,11,12). A cost 
analysis in a large cohort of about 200000 patients revealed that incremental cost for the 
management of CIED infection is about $ 28676 to $ 53349 (compared to 12468 to 36851 for 
uncomplicated  devices), with nearly half of the current incremental cost for intensive care 
(13). Therefore, strategies to shorten the time to explantation, including expedited diagnosis 
are needed.  
Staphylococci are the mean etiological agents (60-80%). Gram negative bacilli 
represent 5-10% of cases and another 10% are negatives cultures. Rarely fungi or 
mycobacteria are involved. CIED related infection may occur either as a surgical site 
infection within 1 year after implantation ( 14 ) or as late-onset lead endocarditis ( 15 ). 
Infections rarely respond to conservative management with antibiotics (16,17,18) and usually 
require complete removal of all hardware (19).Clinical challenges begins at time of diagnosis 
because patients with CIED can present with a variety of manifestations. The decision 
whether to medically treat or remove the device represent an additional important medical 
decision as does the selection of the most appropriate test to deter mine the response to the 
antimicrobial treatment and the most suitable time to implant a new device after the removal 
of the infected one. 
 The diagnosis is generally reached using microbiological tests (blood cultures and 
culture of exudates of the pocket) and transthoracic or transesophageal echocardiography 
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(TTE, TEE). Results of these investigations may be also used to define patients likelihood to 
have infection according to the Duke criteria (20,21). However, in case of CIED infections the 
application of the Duke criteria as they have originally created for the diagnosis of infectious 
endocarditis is troublesome; therefore implementation of the criteria have been proposed (22). 
Even introducing those corrections, there is the possibility to underestimate the extent of the 
infection (23). 
In the recent years, the use of [
18
F]FDG PET/CT has been proposed as a tool to 
improve the diagnosis of CIED infections, potentially impact on patients’ management 
(24,25,26). In fact, a functional imaging modality able to demonstrate through the localization 
of a metabolic-related radiopharmaceutical the presence and the extent of active infection 
might find a place in the diagnostic algorithm of CIED infections. The peculiar possibility to 
follow radiolabeled leukocytes recruitment over time at site of infections as well as the high 
spatial resolution nowadays achievable using hybrid SPECT/CT equipment makes this 
imaging modality a suitable candidate for imaging patients with suspected CIED  infections, 
as already demonstrated in a number of other clinical conditions (27). Therefore, the aim of 
this study is the investigation of the potential of 
99m
Tc-HMPAO autologous leukocyte 
SPECT/CT in patients with suspected device infection to determine the performances of this 
functional tests to guide clinical decisions.  
 
MATERIAL AND METHODS 
Patient Population  
Sixty-three patients (47 men and 16 women, mean age 68,6 ± 13,9; median age 70, 
range 27-87) were referred for 
99m
Tc-HMPAO WBC for the evaluation of known or suspected 
cardiac device infections between June 2007 and December 2010. Patients main clinical 
features and type of devices are reported in Table 1.  
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Table 1. Type of cardiac devices and main clinical features of the patients included in the 
study (PM = pace-maker; ICD = implantable cardioverter defibrillator; ESR = erythrocyte 
sedimentation rate; CRP = C-reactive protein). 
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Type of device single-chamber PM  dual-chamber PM temporary PM single-chamber ICDs dual-chamber ICDs 
 
Infection rate 
30/63 (48%) 
12/30 (40%) 
17/63 (27%) 
7/17 (41%) 
2/63 (3%) 
1/2 (50%) 
9/63 (14%) 
7/9 (78%) 
5/63 (8%) 
3/5 (60%) 
Risk factors Diabetes Renal failure Long term corticoid 
use 
Previous infection Recent invasive procedures 
 17/63 (27%) 11/63 (17%) 7/63 (11%) 8/63 (13%) 30/63 (48%) 
Fever Present 
35/63 (55%) 
Absent 
28/63 (45%) 
   
Time from device 
implant (last procedure, 
months) 
≤ 1  1-3 4-12 > 12 After device removal 
 
Infection rate 
8/63 (13%) 
6/8 (75%) 
13/63 (21%) 
5/13 (38%) 
18/63 (28%) 
8/18 (44%) 
22/63 (35%) 
13/22 (59%) 
2/63 (3%) 
- 
Local inflammation 
signs/symptoms 
Pain  Tenderness Erythema Purulent drainage  
Blood tests ESR PCR Leukocytosis   
 49/63 (77%) 42/63 (67%) 29/63 (46%)   
Blood culture Positive Negative    
 27/63 (43%) 36/63 (57%)*    
         * during antibiotic therapy in 25/56 patients; 4 patients presented either positive EC or pocket culture. 
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The interval between last implantation procedure and symptoms was less than 1 month in 
7/56 patients, 1 to 3 months in 12/56, 4 to 12 months in 17/56, more than 1 year in 20/56. 
A total of 75 scintigraphies were performed since 10 patients have repeated studies (8 with 
two scans, 2 with three scans). Patients were referred for a baseline scan in 56 cases while 19 
examinations were required for the evaluation of patient response to antibiotic therapy and 
used to define its discontinuation. All patients underwent clinical examination, blood tests 
including WBC counts, C-reactive protein, erythrocyte sedimentation rate, acute phase 
proteins, electrophoresis, urine-analysis, either TTE, TEE or both. Three sets of blood cultures 
including at least one aerobic and one anaerobic from a peripheral vein were performed for all 
patients ( 28 ). For patients referred for a diagnostic scan, clinical signs and symptoms 
including the presence of pain, tenderness, erythema and purulent drainage at pocket site as 
well laboratory, and echocardiography results were collected. All patients evaluated to assess 
response to antibiotic therapy presented negative clinical examination, no symptoms/signs or 
persistent infection, negative blood tests, negative echocardiography and negative blood 
cultures.  
Final diagnosis of CIED infections, or exclusion of this condition and identification of an 
alternative cause of disease was defined based on the final microbiological (n = 24) or clinical 
diagnosis (n = 8), with clinical follow-up of 12 months for all patients. All patients without 
microbiological diagnosis repeated 
99m
Tc-HMPAO WBC scintigraphy at the end of the 
antibiotic treatment. Based on these combined parameters, CIED infections were confirmed in 
32 out of the 63 patients (see Table 2). Staphylococcus spp. was the microorganism more 
frequently responsible for the infection (12/28), followed by Streptococcus spp. (3/28), 
Enterococcus spp. (3/28), Enterobacteriaceae spp. (2/28); P. Aeruginosa (2/28); Micrococcus 
and Candida were found in 1/30 patients each. 
 Infection occurred most frequently in single-chamber ICDs (7/9) and dual-chamber 
ICDs (3/5); single and dual chamber PM have similar infection rate (12/30 versus 7/17). One 
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out of the two temporary PM presented infection. Infection was prevalent early after implant 
(5/8 of patients evaluated <1 month and 5/13 cases studied 1-3 months after implantation, 
respectively). Semi-late and late infection were observed in 8/18 patients studied 4-12 months 
and 13/22 patients > 12 months from the procedure. Of interest, 3/5, 5/8 and 11/13 infections 
were after the second procedure  (Table 1).  
Radiopharmaceutical preparation and imaging acquisition protocol  
Autologous radiolabeled WBCs were prepared according to the EANM Guidelines for 
the labeling of leukocytes with 
99m
Tc-HMPAO (29,30). Radiolabelling efficiency was always 
between 70-85%, and viability of the radiolabelled leukocytes was always tested by the 
Tripan blue exclusion test before reinfusion. 
 Whole body and spot planar images were obtained after 30 minutes (early), then 4-6 
and 20-24 hours (delayed images) after reinfusion of 370-555 MBq of 
99m
Tc-HMPAO-WBC. 
SPECT/CT of the chest was performed in all patients at 6 hours and repeated at 24 hours in 
case of negative or doubtful imaging at 6 hours. Images were acquired using a dual-head, 
variable-angle SPECT/CT gamma camera (Hawkeye, GE Healthcare). The low-dose CT 
transmission scan was acquired for 16 seconds over 220° for each transaxial slice. The full 
FOV consisting of 40 slices was completed in 10 minutes. The transmission data were 
reconstructed using filtered back-projection to produce cross-sectional images. Resolution of 
the CT scan was 2.2 mm and localization images were produced with a 4.5-mm pixel size, 
similar to the nuclear medicine emission images. The CT scans were reconstructed into a 
256 256 matrix. The SPECT component of the same FOV was acquired using a 128 128 
matrix, 360° rotation, 6° angle step, and 40/60-sec-per-frame acquisition time at 6 and at 24 
hours, respectively. Both CT-attenuation corrected and non-corrected SPECT images were 
evaluated in the coronal, transaxial, and sagittal planes, as well as in tridimensional maximum 
intensity projection (MIP) cine mode. Matching pairs of x-ray transmission and radionuclide 
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emission images were fused using the Xeleris software, and hybrid images of overlying 
transmission and emission data were generated. 
Interpretation criteria 
All images were revaluated, independently, by two experienced nuclear physicians 
aware of the patients’ clinical history and of the results of prior conventional imaging tests 
reviewed the planar scans and the SPECT/CT images, with regard to the presence and 
location of any focus of abnormal radioactivity accumulation indicating infection. Preliminary 
analysis of the SPECT/CT images included visual inspection to exclude misregistration 
between the SPECT and the CT components. 
The scintigraphic studies were classified as negative when no sites of abnormal uptake 
were observed at SPECT/CT images, or positive for infection when at least one focus of 
abnormal uptake characterized by time-dependent increase in radioactivity from early planar 
to delayed images was observed (31). This time-dependent pattern of uptake is especially 
relevant for the transvenous portions of the lead and cardiac region, considering that 
physiologic accumulation of radiolabeled leukocytes in the bone marrow (as in the clavicle 
and sternum, overlying vessels and the heart) early after reinfusion can interfere with 
interpretation of the planar images. When present, focal uptake indicating infection was 
further classified as pertaining to the heart and/or to extracardiac sites. Positive scans were 
categorized as follow: a) isolated pocket infection; b) isolated lead infection at either 
intravascular or intracardiac portion of the lead; c) pocket and lead infection (either 
intravascular or intracardiac portion); d) extracardiac sites of infection consistent with 
embolism; e) other infections.  
Data Analysis 
Results of 
99m
Tc-HMPAO-WBC scintigraphy were correlated with those of TEE, 
blood culture, the Duke criteria classification and the risk factor category classification (this 
latter only for diagnostic scan). The ability to detect or to exclude the presence of CIED 
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infections was defined based on the final microbiological or clinical diagnosis. Furthermore, 
the ability to identify septic emboli was considered, in order to assess the ability of 
99m
Tc-
HMPAO-WBC scintigraphy to define disease burden. 
For the site-based analysis results of the planar, stand-alone SPECT and SPECT/CT 
images were compared. Stand-alone SPECT and SPECT/CT were considered contributory 
when they provided data that could not be obtained from the assessment of planar images 
concerning the presence of infection or its precise location. The contribution of SPECT/CT 
was considered with special attention to the possibility of anatomically localizing the exact 
site of infection, particularly for vessels and the heart region. The patient-based performance 
of SPECT/CT was compared for the different clinical indications, namely device infection or 
evaluation of the response to antibiotic treatment.  
Statistical analysis 
All values are expressed as median and range, as customary for nonparametric data.  
 
RESULTS 
By adopting the interpretation criteria described above for scintigraphic detection of 
infection, it was possible to classify all the scans as either frankly positive or frankly negative, 
therefore without any equivocal result at scintigraphy.  
With these criteria for interpretation of the diagnostic 
99m
Tc-HMPAO-WBC 
scintigraphies, images were totally negative in 30/75 cases. At least one abnormal area with 
focal uptake of the radiolabeled leukocytes was detected in 45 out of the 75 scans.  
When considering the 32 patients with final diagnosis of CIED infections,
 99m
Tc-
HMPAO-WBC was true positive in 30/32 (94%). Two false negative scans occurred in 
patients with CDIE infections by Candida and Enterococcus (final diagnosis obtained by 
culture of the leads). Both patients were under high-dose antimicrobial therapy at the time of 
scintigraphy. A false negative echocardiography, translating in a Duke rejected classification 
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was present in the first case and a true positive echocardiography and Duke definite 
classification in the second patient. There were no false positive scans for CIED infection. 
Table 2 summarized results of 
99m
Tc-HMPAO-WBC and of ecocardiography and 
patients classification according to Duke criteria in cases of final diagnosis of CIED 
infections.  
 
Table 2. Results of the WBC, echocardiography, Dukes accordingly to the final diagnosis for 
the 75 studies.  
 CDIE infection (n =32) No CDIE infection (n =43) 
WBC 
Positive 30/32 0/43 
Negative 2/32 43/43 
Echocardiography 
Positive 20/32 4/43 
Negative 12/32 39/43 
Duke’s criteria 
Definite 10/32 0/43 
Possible 17/32 10/43 
Rejected 5/32 33/43 
 
Table 3 show results of scintigraphy and echocardiograghy based on time of infection 
onset. Additionally, in this table results of echocardiography are tabulated based on the site of 
radiopharmaceutical uptake at 
99m
Tc-HMPAO-WBC, specifically as involving the pocket (n = 
1), the intravascular and/or intracardiac portion of the lead(s), both the pocket and lead(s).  
 
Table 3. Results of scintigraphy and echocardiograghy based on time of infection onset.
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Type of infection Pocket  
Leads infection Pocket plus lead infection 
Other 
infections 
No infections Intravascular 
lead 
Intracardiac 
lead 
Both 
leads 
Intravascular lead 
Intracardiac 
lead 
Both leads 
Very early, ≤ 1 mo  (n = 10) - - 3 - 1 1 - - 5 
Echo 
pos - - 1 - - 1 - - - 
neg - - 2 - 1 - - - 5 
Early, 1-3 mo (n = 13) - - 3 - - 1 1 1 7 
Echo 
pos - - 3 - - 1 - - - 
neg - - - - - - 1 1 7 
Semi-late, 4-12 mo (n =21)
$
 - 1 6 1 - - - 4 9 
Echo 
pos - - 4 1 - - - - - 
neg - 1 2 0 - - - 4 9 
Late, > 12 mo  (n =29) 1 - 6 1 1 2 1 10 7 
Echo 
pos - - 3  1 - 2  1 2 2 
neg 1 - 3 - 1 - - 8 3 
$
 including 2 FN scintigraphic results.
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Sites of WBC uptake consistent with additional infections (n=38) are also reported, with 
particular attention to the presence of concomitant infectious endocarditis that was present in 
6 cases and distant embolisms (n=15, osteomyelitis in 6 cases, vascular graft and lung in 4 
cases each, and 1 spleen). Vascular graft infections (n=2), osteomyelitis (n=6), mediastinitis 
(n=4), lung infections (n=3) and cholecystitis (n=2) accounts for the other infections. Three 
cases of ocular and cerebral infections remains undiagnosed. None of the patients with 
negative WBC for CIED infection and subsequently treated for the primary cause of infection 
develop CIED infection during the time of the study follow-up.  
 SPECT/CT images were fundamental to localized WBC accumulation and 
differentiate infection of the EC, patch infection and endocarditis.  Importantly analyzing both 
the attenuated corrected and the non-attenuated corrected images no false positive results due 
to artifacts were detected.  
 
DISCUSSION 
The use of a CIED have demonstrated significant benefits in terms of reduction of the 
risk of death and patients better quality of life (32). However, infections of the apparatus can 
darken some of these benefits and recent data point to a disagreeable trend: infection rates are 
rising faster than implantation rates (33). Together with morbidity and even death, infection is 
also associated with significant financial cost for patients and third-party payers. The 
estimated average cost of combined medical and surgical treatment of CIED-related infection 
ranges from $25,000 for permanent pacemakers to $50,000 for implantable cardioverter-
defibrillators (34,35). Further, in the years after initial implantation, device replacement may 
become necessary for battery depletion or for upgrades to more complex multilead 
pacemakers or implantable cardioverter-defibrillator with infection rates higher in 
replacements compared to initial implantation (36,37,38).  
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Therefore, early recognition of infection and accurate quantification of disease burden that 
will determine the selection of the best therapeutic strategies are the two base elements for an 
optimal decision making process.  
In our series, CIED infections was first suspected base on clinical and laboratory 
parameters, subsequently supported by either abnormal echocardiographic findings or local 
signs and further laboratory tests consistent with infection. Further, to confirm the diagnosis 
and to define disease burden, all patients performed WBC scintigraphy. Additionally, we also 
use WBC scintigraphy to evaluate antimicrobial treatment response, to decide its 
discontinuation. 
The use of WBC scintigraphy including SPECT/CT acquisition of the chest, results in 
high sensitivity (94%) for the detection and the localization of CIDE infection. No false 
positive result were found, consistent with the specificity of the diagnostic criteria of 
increased WBC recruitment over time in infectious foci. However, properly due to this 
specific mechanism false negative findings should be take into account in presence of low-
recruiting microorganism (39,40), as in our series in the case of CIED sustained by Candida 
spp. and Enterococcus spp. 
Despite is well known that the majority of infections begin from the pocket by direct 
contamination during the procedure, we detected infection localized at the only pocket in just 
one patient. In the majority of the cases pocket infection was associated with catheter leads 
involvement (7 cases). This data is of importance because of the tendency to underestimate 
infection extent in patients with localized pocket infections. In fact, local manifestations at the 
site of pacemaker implantation has been reported associated with infection of the 
intravascular part of the leads in up to 79% of patients (41). The intracardiac portion of the 
lead was the site more frequently interested by WBC uptake at scintigraphy (24 over a total of 
64 sites of uptake) and it is also associated with the highest rate of complications, either 
infectious endocarditis and/or septic embolism (osteomyelitis, lung, vascular graft) which 
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were found in for a total of 47% of the cases. This finding may be explained by the relatively 
high presence of late infections in the patients we studied (semi-late and late account for more 
of the 50% of the total infections). Infectious endocarditis, present up to 18% of our patients, 
was associated with high frequency of systemic embolism and metastatic infections (lungs, 
bone and spleen). 
In this study, we also evaluated the ability of WBC scintigraphy to rule out the device 
involvement during a febrile episode and sepsis. WBC scintigrafy do exclude the presence of 
device involvement in 43/75 and SPECT/CT images detected causes infections in 15 cases 
(vascular graft infections, osteomyelitis, mediastinitis, lung infections and cholecystitis) with 
sensitivity and specificity of 93% and 91%, respectively.  
All patients in our study performed echocardiography as a first line diagnostic test. In 
our hands, echocardiography results in high specificity 90%, but in a relatively low 
sensitivity, of about 63%. The typical echocardiographic finding of vegetations on the distal 
extreme of the lead (42) was found in 28% of the patients; however, in up to 10% of patients 
lead-associated mass, not representing endocarditis was also detected, in line with previous 
reports (43,44). Additionally, in about 40% of patients, we failed to visualize a mass adherent 
to a lead with TEE, supporting the finding that echocardiography negativity is not sufficient 
to excluding lead infection (45,46,47,48 ). Vegetations observed in our patients for the 
concomitant presence of infectious endocarditis (n = 19%) were easily distinguishable from 
the strands attached to the electrodes that are clinically meaningless. However, the aspect of 
thickening or sleeve that the lead adopts, in our series reported in 6 cases, may represent a 
further difficulty for echocardiographic differential diagnosis ( 49 ). The relatively low 
sensitivity of echocardiography in our series, should be, therefore, partially explained with the 
described technical difficulties and partially with the observation that out of the patients with 
negative TTE/TEE, using WBC scintigraphy we localized infection at the pocket and /or the 
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intravascular portion of the leads (Table 2 and 3) in 5 cases, with a similar frequency in early 
and delayed infections.  
Therefore, comparing TEE and WBC scans only in patients with infections localized 
at the intracardiac portion of the leads, the only trait accurately evaluable with 
echocardiography (in fact, the pocket exploration may results in metal-artifacts and the lead 
portion between pocket and superior cava debouchment remain unexplored), 
echocardiography sensitivity increase to 75%.  
If we apply the Dukes criteria, which entails the echocardiographic findings, to define 
the likelihood to present CIED infection we were able to define the presence of infection in 
31% and 84% of patients, depending of the inclusion of the only Definite category or both the 
Definite plus Possible categories. However, using this latter categorization, specificity of 77% 
should be take into account. This relatively low sensitivity of the Duke criteria may be 
explained by the fact that for the diagnosis of CIED infections it’s not simple possible their 
application in the format originally created for infectious endocarditis. In fact, beside the 
described limitation of echocardiography that would benefit from integration with criteria 
specifically designed for device, the so called minor criteria are just not applicable in this 
setting. Additionally, the pocket assessment which is one of the clinical parameter important 
for the diagnosis of CIED infection, is simply not included.   
Therefore, due to the difficulties that the diagnosis of CIED infection raise, we 
proposed the use of functional imaging modalities to increase diagnostic accuracy and 
perform better a comprehensive clinical assessment in patients at risk of embolism.  
The feasibility and the potential usefulness of radiolabeled leukocytes SPECT/CT in the 
management of infection in a small series of patients with left-ventricular-assist device 
(LVAD) implantation and infectious endocarditis has been recently shown. Leukocyte 
SPECT/CT was able to determine the precise anatomic location and extent of a suspected 
infection, improving patients management (50,51). Similarly, preliminary data on the use of 
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[
18
F]FDG-PET/CT demonstrated promising results in patients with cardiac device, 
particularly when the technique is used to rule out device involvement during infection (52) 
and to define the embolic burden (53,54,55 ). In fact, glucose enhanced metabolism in 
activated leukocytes (56), monocyte-macrophages (57), CD4(+) T-Lymphocytes (58), the 
basic mechanism of [
18
F]FDG accumulation in infectious sites, is shared by a number of 
inflammatory situations (i.e. vasculitis, granulomatosis, sarcoidosis, atherosclerosis) 
(59,60,61,62) as well as post-surgical changes (63,64), making the differential diagnosis, 
especially for early surgical infection, a challenge.  
Therefore, potential application of those imaging modalities may be represented by the 
differential diagnosis between pocket hematoma and purulent collection, fibrous casts or 
thrombus and active vegetations detected by TEE on leads and the definition of the disease 
extent as in presence of ascertained pocket infection. Additionally, we also believe results of 
functional imaging procedure might help clinicians in solving the controversy of the most 
suitable treatment selection, conservative (antimicrobic agents alone or the removal of just the 
generator) versus full hardware extraction, an example of clinical controversy that has been 
risen by the availability of new antimicrobial agents that are able to penetrate into biofilm 
(65). Furthermore, since limited data are available for the decision of antibiotic treatment 
discontinuation and the optimum timing for the placement of a new implantable cardiac 
device following extraction, these medical decision might be also driven by a negative scan. 
Indeed, in this series none of the patients with previous CDIE infection whom treatment 
discontinuation was decided on the base of a negative scan after additional two months of 
reduced antimicrobial therapy either with or without device replacement, presented infection 
recurrence during the study follow-up. 
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CONCLUSION 
In conclusion, our experience supports the use of scintigraphy with 99mTc-HMPAO-WBC in 
patients with high clinical suspicion of CIED infection. 99mTc-HMPAO-WBC scan results 
particularly useful in the evaluation of the pocket and  the lead portion between pocket and 
superior cava debouchment, traits which remain unexplored by TEE. SPECT/CT is necessary 
to demonstrate and localize 99mTc-HMPAO-WBCs uptake. Furthermore, whole-body images 
followed by additional planar and SPECT/CT spot images allow to detect distant sites of 
septic embolism, thus constituting an invaluable aid of this scintigraphic procedure. False 
negative findings may be encountered due to limited spatial resolution or non-leukocyte 
recruiting microorganisms. 
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